{"id":51477,"date":"2026-04-19T10:07:33","date_gmt":"2026-04-19T10:07:33","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/51477\/"},"modified":"2026-04-19T10:07:33","modified_gmt":"2026-04-19T10:07:33","slug":"roche-rog-raises-annual-profit-forecast-as-new-drugs-buoy-sales","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/51477\/","title":{"rendered":"Roche (ROG) Raises Annual Profit Forecast as New Drugs Buoy Sales"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">Roche Holding AG raised its 2024 profit forecast as new drugs like Vabysmo for eye disease drove revenue for the latest quarter and first half of the year.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">Adjusted earnings per share for 2024 will increase in a high-single-digit percentage range at constant exchange rates, the drugmaker said Thursday in a <a href=\"https:\/\/www.bloomberg.com\/news\/terminal\/SH5XW0TP3SHV\" class=\"media-ui-Link_link-tVkXhPLPofs- whitespace-normal\" target=\"_blank\" rel=\"noopener nofollow\" data-component=\"link\">statementBloomberg Terminal<\/a>. Roche had earlier forecast a mid-single-digit percentage increase.<\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding AG raised its 2024 profit forecast as new drugs like Vabysmo for eye disease drove revenue&hellip;\n","protected":false},"author":2,"featured_media":51478,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[114,2112,7437,4397,230,13224,197,23121,10622,13225,304,29321,134,5074],"class_list":["post-51477","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-business","tag-cancer","tag-chief-executive-officer","tag-drugs","tag-earnings","tag-eli-lilly-co","tag-europe","tag-industrials","tag-industries","tag-novo-nordisk-a-s-b","tag-pharmaceutical","tag-prognosis","tag-roche","tag-thomas-schinecker"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116430821451518246","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/51477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=51477"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/51477\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/51478"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=51477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=51477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=51477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}